| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Tract Infections | 29 | 2026 | 342 | 8.200 |
Why?
|
| Pregnancy Complications, Infectious | 23 | 2026 | 514 | 6.280 |
Why?
|
| Placenta | 32 | 2026 | 504 | 6.160 |
Why?
|
| Escherichia coli Infections | 19 | 2026 | 198 | 6.140 |
Why?
|
| Uropathogenic Escherichia coli | 14 | 2026 | 31 | 5.390 |
Why?
|
| Urothelium | 14 | 2026 | 55 | 5.280 |
Why?
|
| Urinary Bladder | 21 | 2026 | 220 | 5.090 |
Why?
|
| Zika Virus Infection | 18 | 2026 | 173 | 5.010 |
Why?
|
| Zika Virus | 18 | 2026 | 150 | 4.380 |
Why?
|
| Infectious Disease Transmission, Vertical | 12 | 2026 | 262 | 2.950 |
Why?
|
| Autophagy | 15 | 2026 | 417 | 2.880 |
Why?
|
| Microbiota | 9 | 2026 | 438 | 2.420 |
Why?
|
| Pregnancy | 47 | 2026 | 7512 | 2.200 |
Why?
|
| Trophoblasts | 9 | 2025 | 113 | 2.130 |
Why?
|
| Nanotubes | 3 | 2026 | 18 | 2.090 |
Why?
|
| Cystitis | 5 | 2023 | 47 | 1.800 |
Why?
|
| Aging | 6 | 2026 | 1242 | 1.780 |
Why?
|
| Pregnancy Outcome | 8 | 2026 | 623 | 1.530 |
Why?
|
| Premature Birth | 8 | 2025 | 428 | 1.470 |
Why?
|
| Bacteria | 5 | 2021 | 521 | 1.400 |
Why?
|
| Placenta Growth Factor | 4 | 2025 | 15 | 1.350 |
Why?
|
| Estrogens | 5 | 2022 | 434 | 1.350 |
Why?
|
| Mice | 53 | 2026 | 18301 | 1.330 |
Why?
|
| Pre-Eclampsia | 5 | 2025 | 226 | 1.290 |
Why?
|
| Fetus | 8 | 2021 | 568 | 1.270 |
Why?
|
| Animals | 65 | 2026 | 33912 | 1.260 |
Why?
|
| Female | 80 | 2026 | 70963 | 1.220 |
Why?
|
| Oxidative Stress | 6 | 2026 | 791 | 1.130 |
Why?
|
| Disease Models, Animal | 17 | 2026 | 4697 | 1.110 |
Why?
|
| Renin-Angiotensin System | 4 | 2025 | 104 | 1.030 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2025 | 85 | 0.980 |
Why?
|
| Quercetin | 1 | 2026 | 11 | 0.950 |
Why?
|
| Reproductive Health | 2 | 2024 | 48 | 0.940 |
Why?
|
| Dasatinib | 1 | 2026 | 49 | 0.930 |
Why?
|
| Interleukin-6 | 6 | 2022 | 412 | 0.930 |
Why?
|
| Cellular Senescence | 2 | 2025 | 217 | 0.930 |
Why?
|
| Proteostasis | 1 | 2026 | 37 | 0.910 |
Why?
|
| Reactive Oxygen Species | 3 | 2025 | 521 | 0.900 |
Why?
|
| Vagina | 7 | 2026 | 208 | 0.890 |
Why?
|
| DNA Damage | 3 | 2026 | 511 | 0.880 |
Why?
|
| Carrier Proteins | 4 | 2013 | 993 | 0.860 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 76 | 0.830 |
Why?
|
| Mice, Inbred C57BL | 19 | 2026 | 4738 | 0.830 |
Why?
|
| Virus Diseases | 3 | 2025 | 285 | 0.810 |
Why?
|
| Humans | 76 | 2026 | 131163 | 0.810 |
Why?
|
| Postmenopause | 2 | 2023 | 137 | 0.800 |
Why?
|
| Organoids | 3 | 2026 | 305 | 0.790 |
Why?
|
| Urinary Tract | 2 | 2022 | 55 | 0.770 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 127 | 0.740 |
Why?
|
| Escherichia coli | 8 | 2023 | 991 | 0.740 |
Why?
|
| rab27 GTP-Binding Proteins | 1 | 2021 | 5 | 0.710 |
Why?
|
| Mesocricetus | 1 | 2021 | 65 | 0.700 |
Why?
|
| Consensus | 2 | 2022 | 512 | 0.700 |
Why?
|
| Models, Biological | 3 | 2026 | 1371 | 0.690 |
Why?
|
| Hydroxychloroquine | 2 | 2018 | 21 | 0.670 |
Why?
|
| Macrophages | 5 | 2023 | 667 | 0.660 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2025 | 44 | 0.650 |
Why?
|
| Financial Management | 1 | 2020 | 13 | 0.640 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 137 | 0.640 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2020 | 9 | 0.630 |
Why?
|
| Science | 1 | 2020 | 36 | 0.620 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 327 | 0.610 |
Why?
|
| Decidua | 1 | 2020 | 143 | 0.600 |
Why?
|
| Urodynamics | 2 | 2018 | 34 | 0.590 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 259 | 0.590 |
Why?
|
| Iron, Dietary | 1 | 2019 | 15 | 0.580 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 633 | 0.580 |
Why?
|
| Antibodies, Viral | 4 | 2021 | 1176 | 0.570 |
Why?
|
| Urination | 1 | 2018 | 23 | 0.560 |
Why?
|
| Epithelial Cells | 4 | 2026 | 905 | 0.560 |
Why?
|
| Regeneration | 3 | 2017 | 230 | 0.560 |
Why?
|
| Inflammation | 9 | 2023 | 1489 | 0.550 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 223 | 0.550 |
Why?
|
| Signal Transduction | 8 | 2024 | 4686 | 0.550 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 639 | 0.550 |
Why?
|
| Cervix Uteri | 2 | 2017 | 57 | 0.540 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 509 | 0.540 |
Why?
|
| Placenta Accreta | 1 | 2020 | 182 | 0.530 |
Why?
|
| Intestinal Mucosa | 3 | 2017 | 771 | 0.520 |
Why?
|
| Parturition | 2 | 2017 | 65 | 0.510 |
Why?
|
| Urologic Neoplasms | 1 | 2017 | 30 | 0.500 |
Why?
|
| Uterus | 1 | 2021 | 541 | 0.490 |
Why?
|
| Viral Nonstructural Proteins | 4 | 2026 | 139 | 0.490 |
Why?
|
| Iron | 2 | 2016 | 304 | 0.490 |
Why?
|
| Genitalia, Female | 1 | 2017 | 44 | 0.490 |
Why?
|
| Metagenomics | 1 | 2017 | 116 | 0.480 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 81 | 0.480 |
Why?
|
| Mice, Knockout | 8 | 2021 | 3819 | 0.480 |
Why?
|
| Host-Pathogen Interactions | 5 | 2021 | 254 | 0.460 |
Why?
|
| Ovariectomy | 2 | 2012 | 152 | 0.460 |
Why?
|
| Fetal Diseases | 5 | 2023 | 440 | 0.450 |
Why?
|
| Microcephaly | 2 | 2019 | 347 | 0.440 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 253 | 0.430 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 1722 | 0.430 |
Why?
|
| HLA-G Antigens | 1 | 2014 | 6 | 0.420 |
Why?
|
| Molecular Biology | 1 | 2014 | 66 | 0.420 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2013 | 21 | 0.410 |
Why?
|
| Autophagy-Related Proteins | 5 | 2021 | 37 | 0.400 |
Why?
|
| Obstetric Labor, Premature | 1 | 2014 | 76 | 0.400 |
Why?
|
| Estradiol | 2 | 2012 | 460 | 0.390 |
Why?
|
| Protamines | 1 | 2012 | 11 | 0.380 |
Why?
|
| Visceral Pain | 1 | 2012 | 7 | 0.380 |
Why?
|
| Chorioamnionitis | 1 | 2013 | 39 | 0.370 |
Why?
|
| Glycosaminoglycans | 1 | 2012 | 42 | 0.360 |
Why?
|
| Bacterial Load | 3 | 2021 | 34 | 0.340 |
Why?
|
| Pandemics | 3 | 2025 | 1118 | 0.340 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2025 | 215 | 0.330 |
Why?
|
| Sex Factors | 2 | 2026 | 1356 | 0.310 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2021 | 52 | 0.310 |
Why?
|
| Prospective Studies | 7 | 2025 | 6459 | 0.300 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2024 | 197 | 0.300 |
Why?
|
| Mannose | 3 | 2023 | 25 | 0.290 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 42 | 0.290 |
Why?
|
| Infant, Premature | 1 | 2014 | 872 | 0.270 |
Why?
|
| Placenta Diseases | 2 | 2020 | 55 | 0.270 |
Why?
|
| Lysosomes | 4 | 2021 | 268 | 0.260 |
Why?
|
| Cytokines | 6 | 2020 | 1339 | 0.260 |
Why?
|
| Brain | 4 | 2018 | 3175 | 0.250 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2006 | 6 | 0.250 |
Why?
|
| Cell Differentiation | 6 | 2024 | 1928 | 0.250 |
Why?
|
| Biological Assay | 3 | 2021 | 105 | 0.240 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2026 | 20 | 0.240 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 377 | 0.230 |
Why?
|
| Unfolded Protein Response | 1 | 2026 | 66 | 0.230 |
Why?
|
| Infant, Newborn | 8 | 2025 | 8635 | 0.230 |
Why?
|
| Immune Evasion | 1 | 2025 | 38 | 0.230 |
Why?
|
| Amygdala | 1 | 2026 | 73 | 0.230 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2025 | 4 | 0.220 |
Why?
|
| Phage Therapy | 1 | 2026 | 50 | 0.220 |
Why?
|
| Virus Replication | 3 | 2017 | 608 | 0.220 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2026 | 128 | 0.220 |
Why?
|
| Viral Load | 3 | 2021 | 416 | 0.220 |
Why?
|
| Reproductive Medicine | 1 | 2024 | 20 | 0.210 |
Why?
|
| Cell Communication | 1 | 2025 | 188 | 0.210 |
Why?
|
| Bacteriophages | 1 | 2026 | 101 | 0.210 |
Why?
|
| Viruses | 1 | 2025 | 117 | 0.210 |
Why?
|
| Allergy and Immunology | 1 | 2024 | 30 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2025 | 80 | 0.200 |
Why?
|
| Phagosomes | 2 | 2014 | 38 | 0.200 |
Why?
|
| Adult | 9 | 2025 | 31282 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 842 | 0.200 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2024 | 179 | 0.200 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2023 | 11 | 0.200 |
Why?
|
| Cell Proliferation | 6 | 2021 | 2465 | 0.200 |
Why?
|
| Monocytes | 2 | 2017 | 335 | 0.190 |
Why?
|
| Fimbriae Proteins | 2 | 2007 | 19 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 3436 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 156 | 0.190 |
Why?
|
| Models, Animal | 2 | 2017 | 450 | 0.190 |
Why?
|
| Lymphoid Tissue | 1 | 2023 | 47 | 0.190 |
Why?
|
| Pluripotent Stem Cells | 2 | 2022 | 83 | 0.190 |
Why?
|
| Endothelium, Vascular | 1 | 2025 | 468 | 0.190 |
Why?
|
| Phosphoproteins | 1 | 2025 | 448 | 0.180 |
Why?
|
| Lymphocyte Subsets | 1 | 2002 | 40 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2022 | 406 | 0.180 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2002 | 84 | 0.180 |
Why?
|
| Virus Internalization | 2 | 2025 | 56 | 0.180 |
Why?
|
| Enterocytes | 1 | 2002 | 68 | 0.180 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2001 | 17 | 0.180 |
Why?
|
| Health Policy | 1 | 2024 | 234 | 0.180 |
Why?
|
| Dimethyl Fumarate | 1 | 2021 | 10 | 0.180 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2021 | 38 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 299 | 0.170 |
Why?
|
| Gestational Age | 3 | 2017 | 1224 | 0.170 |
Why?
|
| Cysts | 1 | 2022 | 80 | 0.170 |
Why?
|
| Mitochondria | 2 | 2025 | 785 | 0.170 |
Why?
|
| Bacteriuria | 2 | 2012 | 80 | 0.170 |
Why?
|
| Adhesins, Bacterial | 1 | 2001 | 74 | 0.170 |
Why?
|
| Cricetinae | 1 | 2021 | 362 | 0.170 |
Why?
|
| Placentation | 2 | 2022 | 59 | 0.170 |
Why?
|
| Coxsackievirus Infections | 1 | 2021 | 9 | 0.170 |
Why?
|
| Enterovirus B, Human | 1 | 2021 | 7 | 0.170 |
Why?
|
| Gardnerella vaginalis | 1 | 2020 | 5 | 0.170 |
Why?
|
| Histones | 1 | 2025 | 541 | 0.170 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2022 | 145 | 0.170 |
Why?
|
| Vaginosis, Bacterial | 1 | 2020 | 18 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2002 | 344 | 0.160 |
Why?
|
| Uterine Diseases | 1 | 2020 | 22 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2021 | 146 | 0.160 |
Why?
|
| Uncertainty | 1 | 2021 | 99 | 0.160 |
Why?
|
| Intestine, Small | 1 | 2002 | 291 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 4 | 2026 | 2596 | 0.160 |
Why?
|
| Societies, Medical | 1 | 2024 | 798 | 0.160 |
Why?
|
| Pain | 1 | 2023 | 450 | 0.150 |
Why?
|
| Streptococcus agalactiae | 1 | 2020 | 106 | 0.150 |
Why?
|
| Urologic Diseases | 2 | 2017 | 42 | 0.150 |
Why?
|
| Stem Cells | 3 | 2011 | 702 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1591 | 0.150 |
Why?
|
| Male | 13 | 2026 | 64957 | 0.150 |
Why?
|
| Fetal Heart | 1 | 2021 | 132 | 0.150 |
Why?
|
| Peritoneal Diseases | 1 | 2019 | 10 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 301 | 0.150 |
Why?
|
| Dysbiosis | 2 | 2020 | 145 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2021 | 801 | 0.140 |
Why?
|
| Uroplakins | 1 | 2018 | 1 | 0.140 |
Why?
|
| Multivesicular Bodies | 1 | 2018 | 2 | 0.140 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2018 | 12 | 0.140 |
Why?
|
| Hepcidins | 1 | 2019 | 26 | 0.140 |
Why?
|
| Endoreduplication | 1 | 2018 | 1 | 0.140 |
Why?
|
| Cell Line | 2 | 2026 | 2552 | 0.140 |
Why?
|
| Polyploidy | 1 | 2018 | 13 | 0.140 |
Why?
|
| Reproduction | 1 | 2020 | 210 | 0.140 |
Why?
|
| Coinfection | 1 | 2020 | 187 | 0.140 |
Why?
|
| Cytokinesis | 1 | 2018 | 23 | 0.140 |
Why?
|
| Metronidazole | 1 | 2019 | 161 | 0.140 |
Why?
|
| Oxysterols | 1 | 2018 | 3 | 0.140 |
Why?
|
| Ferritins | 1 | 2019 | 104 | 0.140 |
Why?
|
| Trehalose | 1 | 2018 | 21 | 0.140 |
Why?
|
| Aminophenols | 1 | 2018 | 14 | 0.140 |
Why?
|
| Phylogeny | 2 | 2018 | 689 | 0.140 |
Why?
|
| Homeostasis | 1 | 2022 | 712 | 0.140 |
Why?
|
| Thermogenesis | 1 | 2018 | 57 | 0.140 |
Why?
|
| Proteomics | 1 | 2022 | 615 | 0.140 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 355 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 2020 | 254 | 0.130 |
Why?
|
| Integrases | 2 | 2010 | 157 | 0.130 |
Why?
|
| Mitosis | 1 | 2018 | 191 | 0.130 |
Why?
|
| Drug Repositioning | 1 | 2018 | 32 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 138 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2017 | 597 | 0.130 |
Why?
|
| Antimalarials | 1 | 2018 | 40 | 0.130 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 49 | 0.130 |
Why?
|
| Spatial Analysis | 1 | 2017 | 26 | 0.130 |
Why?
|
| Viral Vaccines | 2 | 2017 | 324 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2018 | 86 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2018 | 767 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2018 | 232 | 0.120 |
Why?
|
| World Health Organization | 1 | 2017 | 118 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 237 | 0.120 |
Why?
|
| Viral Envelope Proteins | 1 | 2017 | 155 | 0.120 |
Why?
|
| Recurrence | 1 | 2021 | 1489 | 0.120 |
Why?
|
| Siderophores | 1 | 2016 | 11 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 350 | 0.120 |
Why?
|
| Fetal Death | 1 | 2017 | 115 | 0.120 |
Why?
|
| Cell Division | 2 | 2012 | 718 | 0.120 |
Why?
|
| Dengue Virus | 1 | 2017 | 135 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 3748 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2017 | 414 | 0.120 |
Why?
|
| Wnt Proteins | 2 | 2011 | 191 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 2 | 2017 | 525 | 0.120 |
Why?
|
| Endometriosis | 1 | 2019 | 176 | 0.120 |
Why?
|
| Immunity | 2 | 2018 | 178 | 0.120 |
Why?
|
| Epitopes | 1 | 2017 | 324 | 0.120 |
Why?
|
| Research | 1 | 2017 | 264 | 0.120 |
Why?
|
| Escherichia coli Proteins | 2 | 2016 | 319 | 0.110 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2016 | 30 | 0.110 |
Why?
|
| Urinary Bladder Diseases | 2 | 2012 | 26 | 0.110 |
Why?
|
| Cholesterol | 1 | 2018 | 539 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 668 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1801 | 0.110 |
Why?
|
| Brucella | 1 | 2014 | 5 | 0.110 |
Why?
|
| Obstetrics | 1 | 2017 | 235 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 2326 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 981 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 3829 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2018 | 825 | 0.100 |
Why?
|
| Vaginitis | 1 | 2014 | 4 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 1447 | 0.100 |
Why?
|
| United States | 2 | 2024 | 12072 | 0.100 |
Why?
|
| Citrobacter rodentium | 1 | 2013 | 7 | 0.100 |
Why?
|
| Lung | 1 | 2021 | 1535 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1939 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 555 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 526 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2550 | 0.100 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2013 | 60 | 0.100 |
Why?
|
| Drug Implants | 1 | 2012 | 41 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 123 | 0.090 |
Why?
|
| Maternal Age | 1 | 2013 | 136 | 0.090 |
Why?
|
| Transplantation Chimera | 1 | 2012 | 44 | 0.090 |
Why?
|
| Nociception | 1 | 2012 | 12 | 0.090 |
Why?
|
| beta Catenin | 1 | 2013 | 197 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6797 | 0.090 |
Why?
|
| Biomarkers | 4 | 2025 | 3385 | 0.090 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2012 | 47 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1692 | 0.090 |
Why?
|
| Menopause | 1 | 2012 | 85 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1559 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 356 | 0.090 |
Why?
|
| Virulence | 2 | 2009 | 268 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 910 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1490 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2013 | 336 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2013 | 292 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2013 | 408 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 928 | 0.080 |
Why?
|
| Neutrophils | 1 | 2012 | 371 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 199 | 0.080 |
Why?
|
| Autophagosomes | 2 | 2021 | 27 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2023 | 17753 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 589 | 0.070 |
Why?
|
| Apoptosis | 4 | 2016 | 1827 | 0.070 |
Why?
|
| Acute Disease | 1 | 2012 | 1153 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1889 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 478 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 1205 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1826 | 0.070 |
Why?
|
| RNA, Transfer, Leu | 1 | 2007 | 6 | 0.070 |
Why?
|
| Recombinases | 1 | 2007 | 28 | 0.070 |
Why?
|
| Aedes | 2 | 2019 | 103 | 0.070 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2018 | 12 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 3061 | 0.060 |
Why?
|
| Gastric Mucosa | 1 | 2010 | 494 | 0.060 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2006 | 15 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2017 | 148 | 0.060 |
Why?
|
| Endosomes | 1 | 2006 | 70 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2026 | 85 | 0.060 |
Why?
|
| Alleles | 1 | 2010 | 1673 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 992 | 0.060 |
Why?
|
| Aged | 2 | 2021 | 21025 | 0.050 |
Why?
|
| Endocytosis | 1 | 2025 | 121 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2026 | 428 | 0.050 |
Why?
|
| Base Sequence | 2 | 2023 | 2730 | 0.050 |
Why?
|
| Young Adult | 2 | 2016 | 10103 | 0.050 |
Why?
|
| Immune System | 1 | 2023 | 100 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2885 | 0.050 |
Why?
|
| Methenamine | 1 | 2022 | 7 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 59 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2002 | 31 | 0.050 |
Why?
|
| Hippurates | 1 | 2022 | 7 | 0.050 |
Why?
|
| Fluoresceins | 1 | 2022 | 30 | 0.050 |
Why?
|
| Germ-Free Life | 1 | 2002 | 61 | 0.050 |
Why?
|
| Dextrans | 1 | 2022 | 42 | 0.050 |
Why?
|
| Isothiocyanates | 1 | 2022 | 12 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2018 | 1590 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2026 | 687 | 0.050 |
Why?
|
| Claudin-4 | 1 | 2001 | 1 | 0.040 |
Why?
|
| RNA, Complementary | 1 | 2001 | 5 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 263 | 0.040 |
Why?
|
| Wnt-5a Protein | 1 | 2001 | 23 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2023 | 240 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2001 | 58 | 0.040 |
Why?
|
| Virology | 1 | 2021 | 30 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 410 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 201 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 437 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 676 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 325 | 0.040 |
Why?
|
| Microbial Interactions | 1 | 2020 | 14 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2023 | 377 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 122 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2001 | 197 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 116 | 0.040 |
Why?
|
| Mosquito Vectors | 1 | 2019 | 34 | 0.040 |
Why?
|
| RNA | 1 | 2002 | 517 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 22 | 0.040 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 108 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2018 | 5 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 2018 | 54 | 0.030 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2018 | 21 | 0.030 |
Why?
|
| Serotonin | 1 | 2019 | 208 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2018 | 56 | 0.030 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 18 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 133 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 2017 | 19 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2018 | 73 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1652 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 89 | 0.030 |
Why?
|
| Microglia | 1 | 2019 | 147 | 0.030 |
Why?
|
| Autoantigens | 1 | 2018 | 97 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 115 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2017 | 57 | 0.030 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2017 | 12 | 0.030 |
Why?
|
| Blood Cells | 1 | 2017 | 53 | 0.030 |
Why?
|
| Tropism | 1 | 2017 | 7 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 65 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 197 | 0.030 |
Why?
|
| Interferons | 1 | 2018 | 138 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2017 | 226 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2017 | 75 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2017 | 158 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 160 | 0.030 |
Why?
|
| Mycoses | 1 | 2018 | 110 | 0.030 |
Why?
|
| Calcium | 1 | 2001 | 1010 | 0.030 |
Why?
|
| Americas | 1 | 2016 | 52 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 354 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 122 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2016 | 69 | 0.030 |
Why?
|
| Astrocytes | 1 | 2019 | 264 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 135 | 0.030 |
Why?
|
| Asia | 1 | 2016 | 124 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2016 | 164 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 184 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2019 | 324 | 0.030 |
Why?
|
| Endometrium | 1 | 2019 | 292 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2019 | 350 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 826 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2019 | 460 | 0.030 |
Why?
|
| Chemokines | 1 | 2016 | 126 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 721 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 403 | 0.030 |
Why?
|
| Testis | 1 | 2017 | 389 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 387 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 317 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 227 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2016 | 337 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2018 | 327 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 613 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3360 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2016 | 497 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 567 | 0.030 |
Why?
|
| Mutation | 2 | 2018 | 6099 | 0.030 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 450 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2017 | 1021 | 0.020 |
Why?
|
| Lipids | 1 | 2017 | 569 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 127 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3359 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2018 | 804 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1064 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 2200 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 674 | 0.020 |
Why?
|
| Global Health | 1 | 2017 | 626 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5063 | 0.020 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2012 | 11 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2001 | 2406 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6196 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1445 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2114 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1013 | 0.020 |
Why?
|
| Risk Factors | 1 | 2026 | 11074 | 0.020 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 67 | 0.020 |
Why?
|
| Imidazoles | 1 | 2012 | 219 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2010 | 95 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 111 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2010 | 32 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2012 | 269 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1483 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 191 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2011 | 172 | 0.020 |
Why?
|
| Atrophy | 1 | 2010 | 247 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1979 | 0.020 |
Why?
|
| Metaplasia | 1 | 2010 | 215 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2011 | 316 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2011 | 349 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 316 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 576 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 348 | 0.020 |
Why?
|
| Hemagglutination | 1 | 2007 | 7 | 0.020 |
Why?
|
| Genomic Islands | 1 | 2007 | 29 | 0.020 |
Why?
|
| Fimbriae, Bacterial | 1 | 2007 | 39 | 0.020 |
Why?
|
| Gentamicins | 1 | 2007 | 88 | 0.020 |
Why?
|
| Adolescent | 1 | 2026 | 20987 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2007 | 166 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1618 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 1246 | 0.010 |
Why?
|
| Cell Separation | 1 | 2006 | 218 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 1481 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 516 | 0.010 |
Why?
|
| Child | 1 | 2026 | 26341 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1586 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4497 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28601 | 0.010 |
Why?
|